Skip to main content

Depression

  • Chapter
  • First Online:
Clinical Autonomic Dysfunction

Abstract

Depression is associated with parasympathetic excess (PE), whether at rest or during Valsalva or stand. Typically, Valsalva or stand PE is associated with unstable patients, including difficult to control BP, blood glucose, or hormone level, and stand PE can mask sympathetic withdrawal (SW) which is associated with orthostatic dysfunction. In cases of depression, Valsalva or stand PE often involves depression with anxiety, high BP, pain, or hyperactivity, i.e., bipolar, manic depression, anxiety, hypertension with depression, chronic regional pain syndrome, fibromyalgia, chronic fatigue, or attention-deficit disorder with or without hyperactivity. Physiologically, the PE amplifies the sympathetic response, causing a seemingly normal individual at rest to react excessively. Since the sympathetic nervous system is the reactionary nervous system, it should not be surprising that the Valsalva or stand PE is the primary autonomic disorder. Treating the PE enables the sympathetics to react less excessively, normalizing those responses, thereby normalizing BP or other responses. Stand PE masking SW helps to document and treat dizzy hypertensives. Resting PE is associated with clinical or subclinical depression and is the PE that elevates mortality risk in heart disease patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tobias H, Vinitsky A, Bulgarelli RJ, Ghosh-Dastidar S, Colombo J. Autonomic nervous system monitoring of patients with excess parasympathetic responses to sympathetic challenges – clinical observations. US Neurol. 2010;5(2):62–6.

    Google Scholar 

  2. Litchman JH, Bigger Jr JT, Blumenthal JA, et al. Depression and coronary heart disease recommendations for screening, referral, and treatment: A science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118:1768–75.

    Article  Google Scholar 

  3. Carney RM, Blumenthal JA, Freedland KE, Stein PK, Howells WB, Berkman LF, Watkins LL, Czajkowski SM, Hayano J, Domitrovich PP, Jaffe AS. Low heart rate variability and the effect of depression on post–myocardial infarction mortality. Arch Intern Med. 2005;165:1486–91.

    Article  PubMed  Google Scholar 

  4. Silver MA. Depression and heart failure: an overview of what we know and don’t know. Cleve Clin J Med. 2010;77 Suppl 3:S7–11.

    Article  PubMed  Google Scholar 

  5. Barefoot JC, Helms MJ, Mark DB, Blumenthal JA, Califf RM, Haney TL, O’Connor CM, Siegler IC, Williams RB. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol. 1996;78:613–7.

    Article  CAS  PubMed  Google Scholar 

  6. Davidson KW, Rieckmann N, Lesperance F. Psychological theories of depression: potential application for the prevention of acute coronary syndrome recurrence. Psychosom Med. 2004;66:165–73.

    Article  PubMed  Google Scholar 

  7. Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, Newman MF. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med. 2004;66:305–15.

    PubMed  Google Scholar 

  8. Frasure-Smith N, Lesperance F, Gravel G, Masson A, Juneau M, Talajic M, Bourassa MG. Social support, depression, and mortality during the first year after myocardial infarction. Circulation. 2000;101:1919–24.

    Article  CAS  PubMed  Google Scholar 

  9. Lespérance F, Frasure-Smith N, Juneau M, Théroux P. Depression and 1-year prognosis in unstable angina. Arch Intern Med. 2000;160(9):1354–60.

    Article  PubMed  Google Scholar 

  10. Joynt KE, Whellan DJ, O’Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry. 2003;54:248–61.

    Article  PubMed  Google Scholar 

  11. Pereira E, Baker S, Bulgarelli R, Arora RR, Ghosh Dastidar S, Colombo J. Autonomic imbalance may underlie labile hypertension: I. Possible remedy. Clin Auton Res. 2010;20(5):318.

    Google Scholar 

  12. Baker S, Pereira E, Bulgarelli R, Arora RR, Ghosh Dastidar S, Colombo J. Autonomic imbalance may underlie labile hypertension: II. Possible physiology. Clin Auton Res. 2010;20(5):319.

    Google Scholar 

  13. Lagergren K. Effect of exogenous changes in heart rate upon mental performance in patients treated with artificial pacemakers for complete heart block. Br Heart J. 1974;36:1126–32.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Koide H, Kobayashi S, Kitani M, Tsunematsu T, Nakazawa Y. Improvement of cerebral blood flow and cognitive function following pacemaker implantation in patients with bradycardia. Gerontology. 1994;40:279–85.

    Article  CAS  PubMed  Google Scholar 

  15. Barbe C, Puisieux F, Jansen I, Dewailly P, Klug D, Kacet S, DiPompeo C. Improvement of cognitive function after pacemaker implantation in very old persons with bradycardia. J Am Geriatr Soc. 2002;50:778–80.

    Article  PubMed  Google Scholar 

  16. Zimny A, Leszek J, Kiejna A, Sasiadek M. Analysis of correlation between the degree of cognitive impairment and the results of perfusion CT in patients with dementia. Med Sci Monit. 2007;13 Suppl 1:23–30.

    PubMed  Google Scholar 

  17. Chandiramani S, Cohorn LC, Chandiramani S. Heart rate changes during acute mental stress with closed loop stimulation: report on two single-blinded, pacemaker studies. Pacing Clin Electrophysiol. 2007;30:976–84.

    Article  PubMed  Google Scholar 

  18. Malinowski K. Interindividual comparison of different sensor principles for rate adaptive pacing. Pacing Clin Electrophysiol. 1998;21:2209–13.

    Article  CAS  PubMed  Google Scholar 

  19. Griesbach L, Gestrich B, Wojciechowski D, Weyers G, Toenges J, Schier M, Danilovic D. Clinical performance of automatic closed loop stimulation systems. Pacing Clin Electrophysiol. 2003;26:1432–7.

    Article  PubMed  Google Scholar 

  20. Santini M, Ricci R, Pignalberi C, Biancalana G, Censi F, Calcagnini G, Bartolini P, et al. Effect of autonomic stressors on rate control in pacemakers using ventricular impedance signal. Pacing Clin Electrophysiol. 2004;27:24–32.

    Article  PubMed  Google Scholar 

  21. Coenen M, Malinowski K, Spitzer W, Schuchert A, Schmitz D, Anelli-Monti M, Maier SK, et al. Closed loop stimulation and accelerometer-based rate adaptation: results of the PROVIDE study. Europace. 2008;10:327–33.

    Article  PubMed  Google Scholar 

  22. Cook L, Hamilton D, Busse E, Tsang J, Garbe G, Wojcik W, Haennel R. Impact of adaptive rate pacing controlled by a right ventricular impedance sensor on cardiac output in response to exercise. Pacing Clin Electrophysiol. 2003;26:244–7.

    Article  PubMed  Google Scholar 

  23. Puglisi A, Altamura G, Capestro F, Castaldi B, Critelli G, Favale S, Pavia L, et al. Impact of closed-loop stimulation, overdrive pacing, DDDR pacing mode on atrial tachyarrhythmia burden in bradytachy syndrome. A randomized study. Eur Heart J. 2003;24:1952–61.

    Article  CAS  PubMed  Google Scholar 

  24. Bailey WM, Hull D. Closed loop stimulation improves ejection fraction and NYHA class in patients with congestive heart failure and/or ejection fraction <40%. Heart Rhythm. 2005;2(Suppl):S163. Abstract.

    Google Scholar 

  25. Pavri BB, Russell S. An impedance sensor is superior to an accelerometer for chronotropically incompetent patients with sinus node dysfunction: results of a pilot study with a dual sensor pacemaker. Circulation. 2006;114(Suppl II):II749. Abstract.

    Google Scholar 

  26. Lamas GA, Knight JD, Sweeney MO, Mianulli M, Jorapur V, Khalighi K, Cook JR, et al. Impact of rate-modulated pacing on quality of life and exercise capacity – evidence from the advanced elements of pacing randomized controlled trial (ADEPT). Heart Rhythm. 2007;4:1125–32.

    Article  PubMed  Google Scholar 

  27. Wiegand U, Nuernberg M, Maier SKG, Weiss C, Sancho–Tello MJ, Hartmann A, Schuchert A, Maier P, Chan NY. The COGNITION study rationale and design: influence of closed loop stimulation on cognitive performance in pacemaker patients. Pacing Clin Electrophysiol. 2008;31:709–13.

    Article  PubMed  Google Scholar 

  28. Khawaja IS, Westermeyer JJ, Gajwani P, Feinstein RE. Depression and coronary artery disease: the association, mechanisms, and therapeutic implications. Psychiatry (Edgmont). 2009;6:38–51.

    Google Scholar 

  29. May HT, Horne BD, Carlquist JF, Sheng X, Joy E, Catinella AP. Depression after coronary artery disease is associated with heart failure. J Am Coll Cardiol. 2009;53:1440–7.

    Article  PubMed  Google Scholar 

  30. Tomfohr LM, Martin TM, Miller GE. Symptoms of depression and impaired endothelial function in healthy adolescent women. J Behav Med. 2008;31:137–43.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Colombo, J., Arora, R., DePace, N.L., Vinik, A.I. (2015). Depression. In: Clinical Autonomic Dysfunction. Springer, Cham. https://doi.org/10.1007/978-3-319-07371-2_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-07371-2_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-07370-5

  • Online ISBN: 978-3-319-07371-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics